Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

12-week-old Grady, born from cryopreserved testicular tissue. Photo: Oregon Health and Science University

Scientists successfully froze immature testicular tissue and later transplanted it so it could mature and produce sperm that successfully led to a baby in primates — the first time a live birth resulted from a graft of this type of tissue, according to a study published in Science Thursday.

Why it matters: This research is a step towards the goal of allowing young male cancer patients to be able to reproduce later in life if they so choose. As cancer treatments improve, more than 80% of U.S. kids who get cancer now survive but 30% of those will have permanent infertility due to their treatments.

Background: While adult males can undergo successful cryopreservation of their sperm before their treatments start, prepubescent males' stem cells haven't yet gained the ability to turn into sperm.

  • However, several centers around the world have started preserving testicular or ovarian tissues for children undergoing chemotherapy or radiation in anticipation that new therapies will be developed. This includes UPMC in Pittsburgh, which is the base of operations for study author Kyle Orwig.
  • "... In our research laboratory, we are committed to responsibly [developing] the next generation of reproductive therapies that will allow our patients to use their tissues to produce eggs or sperm and have biological children," Orwig tells Axios.

What they did: Over a 2-year period, the research team removed and froze testicular tissue from 5 young rhesus macaques, and implanted the tissue back into the monkeys once they reached puberty.

  • They also implanted a comparison set of fresh, unfrozen samples, and a few months later tested for sperm.

What they found: Both the fresh and frozen tissue had successfully and safely produced sperm.

  • When the sperm from the frozen tissue were used to fertilize 138 eggs, 41% developed into embryos.
  • The scientists transferred 11 embryos into female macaques and one became pregnant and had a baby monkey, named Grady.

"It was important to demonstrate that this would work with frozen and thawed tissues because young cancer patients may need to keep their tissues in cryo-storage for years or even decades before they return to use those tissues to have a child," Orwig says.

These results bring hope to young boys that they could later become fathers using their own sperm, says Susan Taymans, who oversees the funding provided by HHS' National Institute of Child Health and Human Development, which helped pay for this research.

  • "This is an important quality of life issue. Surviving cancer is of course the primary concern, but having survived, patients naturally want a normal healthy life, which includes having the option to father a child," Taymans tells Axios.
  • Monica Laronda, assistant professor of pediatrics at Northwestern University's School of Medicine who was not part of this study, says this work shows "promising results" and was an important step "for moving this research into the clinic."

Yes, but: More research is needed that more closely replicates the procedures humans undergo to see if it would work as well in people, and to determine if there's a risk of the transplant causing a recurrence of the cancer.

  • "Not all cancers will have the same risk for this. ... Maybe in the future it will be possible to screen the tissue without harming it before re-implanting. There are some other conditions besides cancer that are treated with radiation and/or chemo, and those patients would not be at risk of reintroduction of disease when the tissue is grafted back in," Taymans points out.

Go deeper

Updated 56 mins ago - Health

Massage, facial, pedicure... intravenous drip?

A salon on the Upper East Side of New York that offers IV drip therapies. Photo: Jennifer A. Kingson/Axios

IV drips — the kind you might get if you're rushed to the hospital — are trending as a spa treatment, thanks in part to endorsements by celebrities like Kim Kardashian and Madonna.

Why it matters: Like other "wellness" trends with a whiff of medical imprimatur, IV nutrient drips can be harmless or mildly restorative — or go awry, particularly in the wrong hands.

U.S. sounds alarm on Ukraine

Conscripts line up at a Russian railway station yesterday before departing for Army service. Photo: Sergei Malgavko/TASS via Getty Images

The Biden administration is "deeply concerned" by new intelligence — detailed for Axios and other outlets — showing Russia stepping up preparations to invade Ukraine as soon as early 2022.

Why it matters: Most of this was known from public sources and satellite imagery, but the administration is sending a stronger signal by releasing specific details from the intelligence community.

Felix Salmon, author of Capital
3 hours ago - Economy & Business

Philanthropy in the age of crypto

Illustration: Annelise Capossela/Axios

The best charities are increasingly effective. That's the clear message sent by Open Philanthropy, the think tank that doubles as the grant-making vehicle for Facebook co-founder Dustin Moskovitz and his wife Cari Tuna.

Why it matters: With tech and crypto wealth becoming a fast-growing part of the philanthropic pie, there's more of an emphasis than ever on effectiveness — what the newly-divorced Melinda French Gates, in her recent Giving Pledge update, characterizes as giving as "impactfully as possible."